论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
甲状腺癌的血液生物标志物
Authors Wang W, Chang J, Jia B, Liu J
Received 8 May 2020
Accepted for publication 20 June 2020
Published 6 July 2020 Volume 2020:12 Pages 5431—5438
DOI https://doi.org/10.2147/CMAR.S261170
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
Introduction: With the gradual increase in the incidence of thyroid cancer, people’s attention to thyroid cancer has also gradually increased. Although the prognosis of thyroid cancer is rather mild compared to other cancers, it will still bring a heavy psychological burden on people who have been diagnosed. At present, the diagnosis of thyroid cancer mainly depends on ultrasound and percutaneous fine needle aspiration (pFNA). Due to the unsatisfactory accuracy of the diagnosis methods we use now, there are still some thyroid nodules that cannot be clearly diagnosed before surgery.
Methods: In this article, we have searched for relevant research on blood markers of thyroid cancer in the past five years and categoried them into four groups.
Discussion: Though we have not found a biomarker which can diagnose thyroid cancer both sensitively and specifically, we do found many substances that are related to it, and have the potential to recognize it and help the diagnosis. And perhaps combined models can do it better.
Keywords: thyroid neoplasms, blood biomarkers, diagnosis
